Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
17P (Makena) in Preterm Rupture of Membranes
NCT01119963Phase 3Completed
- Sponsor
- Obstetrix Medical Group
- Start
- Oct 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxyprogesterone caproate in preterm birth, sponsored by Obstetrix Medical Group. Started Oct 2011; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT01119963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119963.